The University of Chicago Header Logo

Connection

Scott E. Eggener to Paclitaxel

Back to Details
This is a "connection" page, showing publications Scott E. Eggener has written about Paclitaxel.
Scott E. Eggener
Connection Strength
0.055
Paclitaxel
  1. Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer. Clin Cancer Res. 2005 Jul 01; 11(13):4905-11.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.